Adenylyl Cyclase Signaling in the Developing Chick Heart: The Deranging Effect of Antiarrhythmic Drugs

0438496 - FGÚ 2015 RIV US eng J - Článek v odborném periodiku
Hejnová, L. - Hahnová, K. - Kočková, Radka - Svatůňková, Jarmila - Sedmera, David - Novotný, J.
Adenylyl Cyclase Signaling in the Developing Chick Heart: The Deranging Effect of Antiarrhythmic Drugs.
BioMed Research International. Roč. 2014, č. 2014 (2014), s. 463123. ISSN 2314-6133. E-ISSN 2314-6141
Grant CEP: GA ČR(CZ) GAP302/11/1308
Institucionální podpora: RVO:67985823
Klíčová slova: embryonic heart * embryotoxicity * adenylyl cyclase * G protein * beta-blocking agents
Kód oboru RIV: FA - Kardiovaskulární nemoci vč. kardiochirurgie
Impakt faktor: 1.579, rok: 2014

The adenylyl cyclase (AC) signaling system plays a crucial role in the regulation of cardiac contractility. Here we analyzed the key components of myocardial AC signaling in the developing chick embryo and assessed the impact of selected beta-blocking agents on this system. Application of metoprolol and carvedilol, two commonly used beta-blockers, at embryonic day (ED) 8 significantly downregulated (by about 40%) expression levels of AC5, the dominant cardiac AC isoform, and the amount of Gs alpha protein at ED9. Activity of AC stimulated by forskolin was also significantly reduced under these conditions. Interestingly, when administered at ED4, these drugs did not produce such profound changes in the myocardial AC signaling system, except for markedly increased expression of Gi alpha protein. These data indicate that beta-blocking agents can strongly derange AC signaling during the first half of embryonic heart development
Trvalý link: http://hdl.handle.net/11104/0241940